XTX Markets’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

XTX Markets’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23,448	Closed	-$79K	–	208
2020 Q2	$79K	Buy	+23,448	New	+$68.3K	0.27%	117

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Markets's SPPI Position: Q3 2020 in Review

XTX Markets sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 23,448 shares — an estimated $79K sold.

XTX Markets first reported a position in SPPI in Q2 2020 and held it in 1 quarter. The position peaked at $79K in Q2 2020. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

XTX Markets reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
XTX Markets sold 23,448 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $79K.
XTX Markets first reported a position in Spectrum Pharmaceuticals Inc in Q2 2020 and held it in 1 quarter.
XTX Markets's Spectrum Pharmaceuticals Inc position peaked at $79K in Q2 2020.
159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on XTX Markets's 13F filing for Q3 2020, filed 29 Oct 2020.